Important progress in product development – simultaneous staining in the same section, with high degree of detail
Lumito is developing a novel method for high-contrast imaging without background signal. The first application is developed for tissue diagnostics and digital pathology. In order to visualize cells containing Her2, which is a common marker in breast cancer diagnostics, Lumito is now presenting new images of breast tissues stained with the Company's Her2-UCNP reagent.Lumito's technology makes it possible to stain tissue with nanoparticle-based reagents, and thus to create images with the company’s proprietary analysis instrument. Two of the major advantages are the ability to create imaging